Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GFF MDI vs components and placebo in COPD (China, CTR20150808)
CTR20150808Phase 3Completed
- Sponsor
- Pearl Therapeutics
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of BEVESPI AEROSPHERE in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Jan 2016; status: completed.
02
Drugs
BEVESPI AEROSPHERE
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20150808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150808.